Salts of isobutyric acid (1 R*, 2R*, 4R* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 Hbenzoimidazol-2-yl) -propyl] - methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5en2 -yl

Details for Australian Patent Application No. 2009306002 (hide)

Owner ACTELION PHARMACEUTICALS LTD

Inventors Abele, Stefan; Combes, Stephanie; Funel, Jacques-Alexis; Hilpert, Kurt; Hubler, Francis; Reichenbaecher, Katharina; Renneberg, Dorte; Von Raumer, Markus

Agent A J Park

Pub. Number AU-A-2009306002

PCT Pub. Number WO2010/046857

Priority PCT/ IB2008/054351 22.10.08 IB

Filing date 21 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 235/14 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4184 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/046857 Priority application(s): WO2010/046857

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009306010-Methods for producing antibodies from plasma cells

2009306001-A functionalized cyanine having a silane linker arm, a method of preparing thereof and uses thereof